GEMMUS PHARMA, INC.
|GEMMUS PHARMA, INC. Patent applications|
|Patent application number||Title||Published|
|20120190739||EP2 AND EP4 AGONISTS AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION - The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.||07-26-2012|
|20120190637||COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS - Therapeutics which employ a combination of an antiviral agent and an EP4 receptor agonist for the treatment of human respiratory diseases associated with viral infections are described. Viral infections may include an influenza A virus, for example H1N1, H3N2 and H5N1, and mutations thereof, and/or a coronavirus, for example a virus that causes severe acute respiratory syndrome, “SARS”.||07-26-2012|